ConductScience.org, home

Paper81986

Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease.

O'Donoghue DP and 4 others. Lancet, 1978. Cited by 330 papers, by iCite.

Cite this record

ConductScience Library. Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease. Papers, record 81986. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/81986

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease.
PubMed
Journal
Lancet
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
330
iCite
Relative citation ratio, by iCite
12
iCite
Revised in PubMed
2019-06-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1O'Donoghue DPD P
2Dawson AMA M
3Powell-Tuck JJ
4Bown RLR L
5Lennard-Jones JEJ E

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AzathioprineMajor topic
Crohn DiseaseMajor topic
Substance Withdrawal SyndromeMajor topic
Adult
Aged
Clinical Trials as Topic
Double-Blind Method
Drug Evaluation
Female
Follow-Up Studies
Humans
Male
Middle Aged
Placebos
Recurrence
Remission, Spontaneous
Time Factors

Source PubMed

Download CSV of topics

Cited by73

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 330 citations.

PMIDTitleJournalYearIn PapersSource
41274746AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn's Disease.Gastroenterology2025https://conductscience.org/library/papers/41274746PubMed
41095947Relapse Rates and Predictors Following Azathioprine Withdrawal in Inflammatory Bowel Disease: A Systematic Review, Meta-Analysis, and Meta-Regression.J Clin Med2025https://conductscience.org/library/papers/41095947PubMed
39200937Common Mistakes in Managing Patients with Inflammatory Bowel Disease.J Clin Med2024https://conductscience.org/library/papers/39200937PubMed
38589597Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter study.J Gastroenterol2024https://conductscience.org/library/papers/38589597PubMed
37545640Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study.World J Gastroenterol2023https://conductscience.org/library/papers/37545640PubMed
36776499Normal Ranges of Thiopurine Methyltransferase Activity Do Not Affect Thioguanine Nucleotide Concentrations With Azathioprine Therapy in Inflammatory Bowel Disease.Crohns Colitis 3602020https://conductscience.org/library/papers/36776499PubMed
36773075Treatment escalation and de-escalation decisions in Crohn's disease: Delphi consensus recommendations from Japan, 2021.J Gastroenterol2023https://conductscience.org/library/papers/36773075PubMed
35835862Relapse rates after withdrawal of thiopurines in patients with inflammatory bowel disease.Int J Colorectal Dis2022https://conductscience.org/library/papers/35835862PubMed
35687221Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease.Dig Dis Sci2023https://conductscience.org/library/papers/35687221PubMed
35401955Pancreatitis associated with azathioprine and 6-mercaptopurine use in Crohn's disease: a systematic review.Frontline Gastroenterol2021https://conductscience.org/library/papers/35401955PubMed
34976235Guidelines for the management of patients with Crohn's disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology.Prz Gastroenterol2021https://conductscience.org/library/papers/34976235PubMed
33249621Systematic review with meta-analysis: the effects of immunomodulator or biological withdrawal from mono- or combination therapy in inflammatory bowel disease.Aliment Pharmacol Ther2021https://conductscience.org/library/papers/33249621PubMed
32591969Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy.Dig Dis Sci2021https://conductscience.org/library/papers/32591969PubMed
31364448Immunosuppressive therapies adversely affect blood biochemical parameters in patients with inflammatory bowel disease: a meta-analysis.J Int Med Res2019https://conductscience.org/library/papers/31364448PubMed
31146509Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia.Intest Res2019https://conductscience.org/library/papers/31146509PubMed
29980848The state of the art on treatment of Crohn's disease.J Gastroenterol2018https://conductscience.org/library/papers/29980848PubMed
29961926De-escalation of Therapy in Inflammatory Bowel Disease.Curr Gastroenterol Rep2018https://conductscience.org/library/papers/29961926PubMed
29756637Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/29756637PubMed
26517527Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.Cochrane Database Syst Rev2015https://conductscience.org/library/papers/26517527PubMed
26491502Combination Therapy With Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis.J Clin Med Res2015https://conductscience.org/library/papers/26491502PubMed

See all 73 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/81986

GET https://conductscience.org/api/papers/v1/81986/cited_by?page=2